Adverum Clinical Site 193 — Tampa, Florida

Adverum Clinical Site 193 is a clinical research site located in Tampa, Florida, United States 33617.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Adverum Clinical Site 193 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.

Sponsors: Adverum Biotechnologies, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adverum Clinical Site 193?

Adverum Clinical Site 193 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adverum Clinical Site 193 conducted?

Adverum Clinical Site 193 has 1 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.

Is Adverum Clinical Site 193 accredited by Crixeo Health?

Adverum Clinical Site 193 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Adverum Clinical Site 193?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.